Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

Bullboard Posts

Comment by Markonion Mar 29, 2020 12:40pm

94 Views

Post# 30857562

RE:RE:Alldown, I appreciate what you said and I don't feel

Go downhill,

Deteriorate, worsen, as in Ever since the recession began, the business has been going downhill. The figurative use of downhill for “decline” dates from the mid-1800s. Also see downhill all the way.

https://www.dictionary.com/browse/go-downhill

I guess it is a matter of perspective.

Good luck.

Markoni

Bullboard Posts

Visionstate set to leverage success in the U.S. market